• Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml
  • Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml
  • Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml
  • Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml
  • Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml
  • Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml

Cerave Retinol Serum For Post-Acne Marks - Imperfection-Prone Skin - 30ml

DZD4,450.00
  • 💆‍♀️ Retinol serum to reduce post-breakout marks
  • ✨ Ceramide and niacinamide enriched formula for even skin tone
  • 🌙 Night routine - must be paired with daytime sunscreen
  • 🧴 Lightweight texture that blends easily into your skincare routine
  • 🔬 Developed with dermatologists for sensitive skin

Regenerating Serum by CeraVe

The Retinol Serum for Post-Acne Marks by CeraVe is specially formulated for imperfection-prone skin. Its unique composition combines retinol, ceramides and niacinamide for complete action on skin marks.

Key Benefits
  • Visibly reduces the appearance of post-acne marks
  • Gently exfoliates for smoother, more even skin tone
  • Nourishes and strengthens skin barrier with ceramides
  • Improves skin radiance with niacinamide
  • Non-comedogenic formula suitable for sensitive skin
How to Use

Apply in the evening on clean, dry skin. Start with weekly use, then gradually increase according to your skin's tolerance. Essential: always use sunscreen the following day.

At Louzio.com, we offer only authentic products, carefully checked before shipping. The item shown (barcode: 3337875829007) exactly matches the visuals and descriptions.

Complete Routine

For optimal results, pair this serum with CeraVe Acne Control Cleanser morning and night, and complete with AM Facial Moisturizing Lotion SPF 50 for daily protection.

  • Brand
  • Reference
    3337875829007
  • EAN13
    3337875829007

You might also like

Comments (0)

No customer reviews for the moment.
Loading...